Skip to content
← Holders

PSP Research LLC

What PSP Research LLC reported holding on Form 13F for the quarter ended Sep 30, 2026.

CIK 2106939 · Filed Oct 21, 2026

Positions
44
Reported value
$145.8M
Opened
1
Closed
32
Other managers included
0

Values are as the managers reported them, in dollars.Open the Form 13F on SEC EDGAR

Quarters on file

  1. Dec 31, 2025$114.4M
    85 positions
  2. Mar 31, 2026$141.3M
    79 positions
  3. Jun 30, 2026$187.9M
    75 positions
  4. Sep 30, 2026$145.8M
    44 positions
SecuritySharesChangeValueOf portfolio
ISHARES TR0-3 MTH TREASURY
700K±0%$70.5M48.3%
SPDR SERIES TRUSTST STR SP BIOT
386.5K−32.2%$60.9M41.8%
SERASera Prognostics, Inc.
2.4MNew$5M3.4%
HALOHalozyme Therapeutics, Inc.
3K−57.1%$331.2K0.2%
MDGLMadrigal Pharmaceuticals, Inc.
600±0%$302.4K0.2%
EXELExelixis, Inc.
5K−37.5%$292.1K0.2%
RPRXRoyalty Pharma plc
5K−54.5%$291.8K0.2%
ARGXArgenx SE
300−53.2%$287.7K0.2%
NRIXNurix Therapeutics, Inc.
12K−52.0%$284.5K0.2%
TGTXTG Therapeutics, Inc.
5K−50.0%$278.9K0.2%
TARSTarsus Pharmaceuticals, Inc.
3.5K−50.0%$275.1K0.2%
HRMYHarmony Biosciences Holdings, Inc.
7K−30.0%$274.8K0.2%
ARQTArcutis Biotherapeutics, Inc.
10K−49.2%$264.3K0.2%
KNSAKiniksa Pharmaceuticals International, plc
3.5K−30.0%$261.1K0.2%
SUPNSupernus Pharmaceuticals, Inc.
6K±0%$258.2K0.2%
IMNMImmunome Inc.
12K−33.3%$258.1K0.2%
NBIXNeurocrine Biosciences Inc
1.8K−40.0%$255.3K0.2%
ORKAOruka Therapeutics, Inc.
3K±0%$249.9K0.2%
TNGXTango Therapeutics, Inc.
10K±0%$249.5K0.2%
DFTXDefinium Therapeutics, Inc.
6.5K−35.0%$247.4K0.2%
RVMDRevolution Medicines, Inc.
1.2K±0%$246.3K0.2%
ALKSAlkermes plc.
6K±0%$243.1K0.2%
AUPHAurinia Pharmaceuticals Inc.
15K−50.0%$242.9K0.2%
INCYIncyte Corp
2K−62.3%$242.7K0.2%
NTLAIntellia Therapeutics, Inc.
20K±0%$241.2K0.2%
IMVTImmunovant, Inc.
7K−46.2%$236.5K0.2%
STOKStoke Therapeutics, Inc.
9K−25.0%$234K0.2%
KRYSKrystal Biotech, Inc.
692±0%$230.1K0.2%
ASNDAscendis Pharma A/S
1K−33.3%$227.8K0.2%
SNDXSyndax Pharmaceuticals Inc
12K−40.0%$225.6K0.2%
KYMRKymera Therapeutics, Inc.
2K−50.0%$223.6K0.2%
DNTHDianthus Therapeutics, Inc.
2.5K±0%$220.1K0.2%
TRVITrevi Therapeutics, Inc.
15K−50.0%$214.8K0.1%
MIRMMirum Pharmaceuticals, Inc.
2.5K±0%$213.7K0.1%
IMCRImmunocore Holdings plc
7K−53.8%$212K0.1%
PTGXProtagonist Therapeutics, Inc
1.5K−50.0%$211.3K0.1%
EWTXEdgewise Therapeutics, Inc.
5K±0%$203K0.1%
ORICOric Pharmaceuticals, Inc.
13K±0%$175.1K0.1%
DYNDyne Therapeutics, Inc.
10K−50.0%$161.1K0.1%
CMPSCOMPASS Pathways plc
10K−44.4%$124.4K0.1%
OCULOcular Therapeutix, Inc
15K±0%$115.1K0.1%
CTMXCytomX Therapeutics, Inc.
39.4K±0%$107.2K0.1%
ARDXArdelyx, Inc.
30K−50.0%$102.6K0.1%
OLMAOlema Oncology, Inc.
10K±0%$86.4K0.1%